MedTrace Logo

Enhancing Skin Rejuvenation Using Laser and Exosomes

NCT07281690 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-12-15

No results posted yet for this study

Summary

Enhancing Skin Rejuvenation A Single-Blind, Randomized Control Study on the Combined Efficacy of Aerolase 1064 nm YAG Laser and Exosomes Derived from Umbilical Cord Mesenchymal Stem Cells

Conditions

  • Laser Therapy
  • Exosomes

Interventions

DEVICE

1064-nm Nd:YAG Laser Treatment

A non-ablative 1064-nm Nd:YAG laser (Aerolase Neo Elite) delivered to the entire face at each treatment visit.

BIOLOGICAL

Topical Umbilical Cord-Derived Exosomes (UC-MSC Exosomes)

Description: Topical application of a laboratory-processed umbilical cord lining mesenchymal stem-cell-derived exosome serum. Applied twice daily to the randomly assigned half of the face for 60 days following each laser session. Other Name: Exosome serum; UC-MSC exosome solution.

Sponsors & Collaborators

  • Laser Beamer Skincare

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-03-01
Primary Completion
2025-07-17
Completion
2025-07-17
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07281690 on ClinicalTrials.gov